Blog Image

The 2026 CRUSH Initiative: How New CMS Rules Could Halt DMEPOS & Pharmacy Growth

In 2026, CMS has introduced sweeping enforcement changes impacting DMEPOS suppliers and pharmacies nationwide. A new enrollment moratorium, real-time data monitoring, and stricter ownership rules are creating significant barriers to expansion and increasing audit risk. Providers must act proactively to protect billing privileges, maintain compliance, and avoid operational disruptions.

A Nationwide Enrollment Freeze for DMEPOS Providers

On February 27, 2026, CMS enacted a six-month nationwide moratorium on new Medicare enrollments for select DMEPOS categories under the CMS-6099-N notice.

This means:

  • No new PTANs (Medicare billing numbers) will be issued for affected categories

  • Applications submitted after the effective date will be denied outright

  • The moratorium is expected to remain in place through at least August 2026

This freeze does not just affect new businesses. It also impacts:

  • Providers expanding into new locations

  • Organizations undergoing ownership changes requiring re-enrollment

  • Suppliers attempting to add new DMEPOS service lines

For many pharmacies and DMEPOS providers, what was once a routine expansion process has effectively become paused at the federal level.


The “CRUSH” Initiative: Real-Time Data Enforcement

At the core of this shift is what many in the industry are referring to as the CRUSH initiative—a move toward real-time, cross-agency data enforcement.

Historically, Medicare (federal) and Medicaid (state) systems operated with limited coordination. That separation allowed inconsistencies in reporting to go unnoticed for extended periods.

That gap has now closed.

CMS is actively using advanced analytics and automated data matching to compare:

  • Medicare billing activity

  • State-level tax filings

  • 1099 income reporting

  • Operational and staffing data

If discrepancies are detected—such as reported income not aligning with billing volume—the system can trigger immediate audit activity.

This represents a fundamental shift from reactive enforcement (“pay and chase”) to proactive claim monitoring and denial.


The Medicaid Spillover Effect: Multi-State Risk Exposure

One of the most significant implications of the CRUSH initiative is how quickly compliance issues can now spread across payer systems.

If a provider is flagged at the Medicare (federal) level, that information can now be shared directly with state Medicaid agencies.

This creates a cascading risk:

  • A Medicare discrepancy can trigger state-level investigations

  • Medicaid reimbursement can be delayed, reduced, or suspended

  • Commercial payer contracts may also be impacted

Recent enforcement activity has already demonstrated the scale of this shift. In one case, CMS deferred hundreds of millions in Medicaid funding after identifying billing anomalies that state systems failed to catch in time.

Examples of flagged patterns included:

  • Billing volumes inconsistent with reported staffing levels

  • Claims suggesting impossible operational capacity (e.g., continuous 24-hour billing over extended periods)

For providers, this means compliance is no longer siloed. A single issue can now affect every payer relationship simultaneously.


States Currently Under Heightened Oversight

Providers operating in the following regions should be especially cautious, as these states are currently seeing increased scrutiny under coordinated federal and state oversight efforts:

Northeast
Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

South
Alabama, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, South Carolina, Virginia, West Virginia

Midwest
Illinois, Indiana, Michigan, Minnesota, Ohio

West
Arizona, California, Nevada

Territories
United States Virgin Islands

If your pharmacy or DMEPOS operation spans multiple states, maintaining consistent, accurate reporting across all jurisdictions is now essential.


The 36-Month Rule: A Hidden Barrier to Ownership Changes

Another critical compliance issue is the 36-month rule, which has taken on new importance under the current moratorium.

As of January 1, 2026:

  • If your organization has been enrolled in Medicare for less than 36 months

  • And you transfer more than 50% ownership

CMS may classify the change as a new enrollment.

Under normal conditions, this would trigger a re-enrollment process. However, due to the current moratorium:

  • New enrollments are blocked

  • The ownership transition may be effectively prevented

This creates a serious constraint for:

  • Business sales

  • Partnerships or equity restructuring

  • Expansion through acquisition

For affected organizations, ownership flexibility is now directly tied to regulatory timing and compliance status.


What to Expect Next: Real-Time Enforcement Is Here

CMS is continuing to move toward a real-time compliance environment.

Emerging enforcement trends include:

  • Shortened documentation and filing windows

  • Increased pre-payment claim reviews

  • Automated claim denials for incomplete or inconsistent data

  • Greater reliance on data validation across systems before approval

The traditional model of submitting claims and resolving issues later is being replaced by front-end enforcement, where claims may be denied before payment is ever issued.

For pharmacies and DMEPOS providers, this means:

  • Documentation must be accurate and complete at submission

  • Accreditation records must align exactly with billed services

  • Enrollment data must remain fully synchronized across all systems

Any gap in these areas can result in delayed payments, denied claims, or enrollment actions.


How PACCS Helps Pharmacies Navigate CMS Enforcement Changes

As Medicare and Medicaid oversight becomes more complex, maintaining compliance across multiple systems and timelines requires ongoing attention and expertise.

PACCS (Pharmacy Administrative Credentialing & Compliance Services) supports pharmacies and DMEPOS providers with:

  • Medicare and Medicaid enrollment management

  • DMEPOS credentialing and accreditation coordination

  • Ownership change and re-enrollment strategy

  • NPI, PECOS, and payer data alignment

  • Ongoing compliance monitoring and deadline tracking

  • Payer communication and issue resolution

By proactively managing enrollment data and compliance requirements, PACCS helps organizations avoid disruptions, protect billing privileges, and maintain operational continuity.

To learn more, visit our Services page or contact PACCS to discuss how we can support your pharmacy or DMEPOS operation.


Sources

https://www.federalregister.gov/documents/2026/02/27/2026-03945/medicare-medicaid-and-childrens-health-insurance-programs-provider-enrollment-application-fee-and&authuser=1

https://www.cms.gov/newsroom/press-releases/trump-administration-prioritizes-affordability-announcing-major-crackdown-health-care-fraud

https://hallrender.com/2026/02/12/36-month-rule-applies-to-dmepos-suppliers-effective-january-1-2026/

https://hallrender.com/2026/03/06/cms-issues-sweeping-anti-fraud-rfi-under-new-crush-initiative/

https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/downloads/dmepos_basics_factsheet_icn905710.pdf

Investigative Dispatch — PACCS Editorial Series

Insights on regulatory developments affecting pharmacy credentialing, Medicare enrollment, and compliance.

Sterling Bly | Investigative Healthcare Blogger